Pharmacokinetic and Pharmacodynamic Properties of Batifiban Coadministered with Antithrombin Agents in Chinese Healthy Volunteers

被引:0
|
作者
何晓梦 [1 ]
周莹 [1 ]
李杰 [1 ]
伍三兰 [1 ]
贾萌萌 [1 ]
刘明周 [1 ]
谌辉 [1 ]
谌科 [2 ]
李圣峰 [3 ]
王耀华 [3 ]
黎维勇 [1 ]
机构
[1] Institute of Clinical Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
[2] Department of Infection Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
[3] Biothera Solutions
关键词
D O I
暂无
中图分类号
R969 [临床药理学];
学科分类号
摘要
The combined use of batifiban, a synthetic platelet GPⅡ b/Ⅱ a receptor antagonist, and antithrombin agents is an attractive option for the treatment of patients with non-ST-segment elevation(NSTE) acute coronary syndrome(ACS) and those scheduled for percutaneous coronary intervention.To observe whether antithrombin agents affect the pharmacokinetic and pharmacodynamic properties of batifiban in combination therapy and optimize clinical administration dosage of batifiban, an open-label and parallel study was conducted. Thirty healthy subjects were randomly divided into three groups,which were sequentially treated with batifiban alone, or oral coadministration of clopidogrel, aspirin and UFH, or batifiban coadministered with these antithrombin agents. Blood samples were collected at pre-specified time points. The evaluation index included the inhibition of platelet aggregation and pharmacokinetic parameters. The pharmacokinetic parameters of batifiban and batifiban coadministered with antithrombin agents showed no significant differences. The mean inhibition rate of platelet aggregation(%) suggested that neither batifiban alone nor antithrombin agents alone could provide such potent inhibition rate(>80%) to obtain the best clinical efficacy, but they had a synergistic effect on platelet inhibition. No serious adverse effects were observed. The results in these healthy subjects suggest that batifiban coadministrated with antithrombin agents could achieve optimum clinical treatment effect for patients with NSTE ACS, and also those scheduled for percutaneous coronary intervention.
引用
收藏
页码:786 / 790
页数:5
相关论文
共 50 条
  • [31] Effect of Food on the Pharmacokinetic and Pharmacodynamic Profiles of Hetrombopag in Healthy Volunteers
    Wang, Zhenlei
    Chen, Xiaogang
    Li, Aiwei
    Chen, Li
    Wang, Yongsheng
    Zheng, Li
    CLINICAL THERAPEUTICS, 2020, 42 (12) : 2280 - 2288
  • [32] Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers
    Marzo, A
    Dal Bo, L
    Mazzucchelli, P
    Monti, NC
    Crivelli, F
    Ismaili, S
    Giusti, A
    Uhr, MR
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2002, 52 (04): : 233 - +
  • [33] PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIP AND PHARMACOGENETICS OF METFORMIN IN HEALTHY VOLUNTEERS
    Chung, H.
    Oh, J.
    Chung, I.
    Kim, Y.
    Yoon, S.
    Cho, J.
    Chung, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S58 - S58
  • [34] PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF DOBUTAMINE INFUSIONS IN HEALTHY-VOLUNTEERS
    BERG, RA
    PADBURY, JF
    KLEWER, SE
    DONNERSTEIN, RL
    HUTTER, JJ
    PEDIATRIC RESEARCH, 1991, 29 (04) : A57 - A57
  • [35] INTRAMUSCULAR ATROPINE IN HEALTHY-VOLUNTEERS - A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY
    KENTALA, E
    KAILA, T
    IISALO, E
    KANTO, J
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1990, 28 (09) : 399 - 404
  • [36] Lesinurad: Evaluation of Pharmacokinetic and Pharmacodynamic Interactions With Warfarin in Healthy Volunteers
    Shen, Zancong
    Lee, Caroline A.
    Wallach, Kathleen
    Valdez, Shakti
    Wilson, David M.
    Kerr, Bradley
    Gillen, Michael
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (05): : 657 - 663
  • [37] Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers
    Booker, BM
    Magee, MH
    Blum, RA
    Lates, CD
    Jusko, WJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (04) : 370 - 382
  • [38] Pharmacokinetic and Pharmacodynamic Modeling Analysis of Intravenous Esomeprazole in Healthy Volunteers
    Liu, Dongyang
    Yang, Hong
    Jiang, Ji
    Nagy, Peter
    Shen, Kai
    Qian, Jiaming
    Hu, Pei
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (07): : 816 - 826
  • [39] PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF TIENILIC ACID IN HEALTHY-VOLUNTEERS
    KERREMANS, ALM
    GRIBNAU, FWJ
    TAN, Y
    VANGINNEKEN, CAM
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (06) : 515 - 521
  • [40] PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION OF OBETICHOLIC ACID AND BEZAFIBRATE IN HEALTHY VOLUNTEERS
    Burkey, Jennifer
    Brown, Karen
    Zou, Heng
    Boston, Jennifer
    Erickson, Mary
    HEPATOLOGY, 2024, 80 : S1841 - S1841